These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 17032428)

  • 1. Rabbit antithymocyte globulin related decrease in platelet count reduced risk of pediatric renal transplant graft thrombosis.
    Kamel MH; Mohan P; Conlon PJ; Little DM; O'Kelly P; Hickey DP
    Pediatr Transplant; 2006 Nov; 10(7):816-21. PubMed ID: 17032428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rabbit antithymocyte globulin as induction immunotherapy for pediatric deceased donor kidney transplantation.
    Kamel MH; Mohan P; Little DM; Awan A; Hickey DP
    J Urol; 2005 Aug; 174(2):703-7. PubMed ID: 16006954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced dose rabbit anti-thymocyte globulin induction for prevention of acute rejection in high-risk kidney transplant recipients.
    Klem P; Cooper JE; Weiss AS; Gralla J; Owen P; Chan L; Wiseman AC
    Transplantation; 2009 Oct; 88(7):891-6. PubMed ID: 19935460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of induction based on continuous vs discontinuous administration of antithymocyte globulins in renal transplant patients: efficacy and long-term safety.
    Esposito L; Kamar N; Durand D; Rostaing L
    Transplant Proc; 2005 Mar; 37(2):892-4. PubMed ID: 15848567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of extended-duration inpatient-to-outpatient rabbit antithymocyte globulin induction in de novo kidney transplant recipients: 6-month outcomes.
    Trofe-Clark J; Reese PP; Patel HJ; Jakobowski D; Goral S; Doll SL; Abt PL; Bloom RD
    Transplantation; 2012 Sep; 94(5):506-12. PubMed ID: 22895613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcome after kidney transplantation in children with thrombotic risk factors.
    Kranz B; Vester U; Nadalin S; Paul A; Broelsch CE; Hoyer PF
    Pediatr Transplant; 2006 Nov; 10(7):788-93. PubMed ID: 17032424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors and consequences of delayed graft function in deceased donor renal transplant patients receiving antithymocyte globulin induction.
    Patel SJ; Duhart BT; Krauss AG; Moore LW; Egidi MF; Amiri HS; Gaber LW; Gaber AO
    Transplantation; 2008 Jul; 86(2):313-20. PubMed ID: 18645496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Excellent renal allograft survival in donor-specific antibody positive transplant patients-role of intravenous immunoglobulin and rabbit antithymocyte globulin.
    Mai ML; Ahsan N; Wadei HM; Genco PV; Geiger XJ; Willingham DL; Taner CB; Hewitt WR; Grewal HP; Nguyen JH; Hughes CB; Gonwa TA
    Transplantation; 2009 Jan; 87(2):227-32. PubMed ID: 19155977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of intraoperative versus postoperative administration of rabbit antithymocyte antibodies on 1-year renal function in renal transplant patients.
    Kamar N; Esposito L; Ribes D; Tkaczuk J; Cointault O; Lavayssiere L; Abbal M; Durand D; Rostaing L
    Exp Clin Transplant; 2006 Jun; 4(1):429-38. PubMed ID: 16827639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rabbit antithymocyte globulin as induction immunotherapy in pediatric heart transplantation.
    Di Filippo S; Boissonnat P; Sassolas F; Robin J; Ninet J; Champsaur G; Bozio A
    Transplantation; 2003 Feb; 75(3):354-8. PubMed ID: 12589158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized trial of single-dose versus divided-dose rabbit anti-thymocyte globulin induction in renal transplantation: an interim report.
    Stevens RB; Mercer DF; Grant WJ; Freifeld AG; Lane JT; Groggel GC; Rigley TH; Nielsen KJ; Henning ME; Skorupa JY; Skorupa AJ; Christensen KA; Sandoz JP; Kellogg AM; Langnas AN; Wrenshall LE
    Transplantation; 2008 May; 85(10):1391-9. PubMed ID: 18497677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of small variations in the delivered dose of rabbit antithymocyte induction therapy in kidney transplantation with early corticosteroid withdrawal.
    Tsapepas DS; Mohan S; Tanriover B; Dube G; Crew RJ; Cohen DJ; Hardy MA; Sandoval PR; Ratner LE
    Transplantation; 2012 Aug; 94(4):325-30. PubMed ID: 22814328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 20-year follow-up results of a randomized controlled trial comparing antilymphocyte globulin induction to no induction in renal transplant patients.
    Cantarovich M; Durrbach A; Hiesse C; Ladouceur M; Benoit G; Charpentier B
    Transplantation; 2008 Dec; 86(12):1732-7. PubMed ID: 19104413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of prophylactic rabbit antithymocyte globulin in cardiac allograft recipients treated with cyclosporine.
    Kawaguchi A; Szentpetery S; Mohanakumar T; Barnhart GR; Lower RR
    J Heart Transplant; 1987; 6(4):214-7. PubMed ID: 3312532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Administration of rabbit antithymocyte globulin (thymoglobulin) in ambulatory renal-transplant patients.
    Marvin MR; Droogan C; Sawinski D; Cohen DJ; Hardy MA
    Transplantation; 2003 Feb; 75(4):488-9. PubMed ID: 12605115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pediatric kidney transplantation is safe and available for patients with urological anomalies as well as those with primary renal diseases.
    Morita K; Iwami D; Hotta K; Shimoda N; Miura M; Watarai Y; Hoshii S; Obikane K; Nakashima T; Sasaki S; Nonomura K
    Pediatr Transplant; 2009 Mar; 13(2):200-5. PubMed ID: 18662371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deep vein thrombosis during rabbit antithymocyte globulin administration.
    Mathis AS; Rao V
    Transplant Proc; 2004 Dec; 36(10):3250-1. PubMed ID: 15686740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and economic outcomes of rabbit antithymocyte globulin induction in adults who received kidney transplants from living unrelated donors and received cyclosporine-based immunosuppression.
    Miller JT; Collins CD; Stuckey LJ; Luan FL; Englesbe MJ; Magee JC; Park JM
    Pharmacotherapy; 2009 Oct; 29(10):1166-74. PubMed ID: 19792990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction therapy with either anti-CD25 monoclonal antibodies or rabbit antithymocyte globulins in liver transplantation for hepatitis C.
    Kamar N; Borde JS; Sandres-Saune K; Suc B; Barange K; Cointault O; Lavayssière L; Durand D; Izopet J; Rostaing L
    Clin Transplant; 2005 Feb; 19(1):83-9. PubMed ID: 15659139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicoepidemiologic study of posttransplant diabetes after living-donor renal transplant.
    Elmagd MM; Bakr MA; Metwally AH; Wahab AM
    Exp Clin Transplant; 2008 Mar; 6(1):42-7. PubMed ID: 18405244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.